At close: December 20 at 4:00:01 PM EST
After hours: December 20 at 4:09:34 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 1,077,000 | 13 |
Sales | 87,702 | 3 |
Net Shares Purchased (Sold) | 989,298 | 16 |
Total Insider Shares Held | 8.52M | -- |
% Net Shares Purchased (Sold) | 13.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
HAWKINS RICHARD JAMES Director | Sale at price 3.32 per share. | Direct | 26,569 | Dec 16, 2024 |
LOWRANCE DAVID L. CPA Chief Financial Officer | Sale at price 3.33 per share. | Direct | 83,278 | Dec 16, 2024 |
PAULS MATTHEW Chief Executive Officer | Sale at price 3.31 per share. | Direct | 180,828 | Dec 16, 2024 |
LOWRANCE DAVID L. CPA Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 13, 2024 |
HAWKINS RICHARD JAMES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
ELAM NEVAN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
LOWRANCE DAVID L. CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
PRATT RAYMOND DENNIS M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
PAULS MATTHEW Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
MCCRACKEN JOSEPH S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
LUTZ ROBERT MATTHEW Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
VAN ES-JOHANSSON AN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
ERICKSON ANNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
PARKER BRADEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2024 |
MCCRACKEN JOSEPH S Director | Purchase at price 2.95 per share. | Direct | 59,072 | Nov 19, 2024 |
PARKER BRADEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 25, 2024 |
ELAM NEVAN C Director | Sale at price 4.71 per share. | Direct | 442,291 | Dec 28, 2023 |
LOWRANCE DAVID L. CPA Chief Financial Officer | Sale at price 4.71 per share. | Direct | 47,131 | Dec 28, 2023 |
PAULS MATTHEW Chief Executive Officer | Sale at price 4.71 per share. | Direct | 395,900 | Dec 28, 2023 |
ELAM NEVAN C Director | Conversion of Exercise of derivative security at price 0.82 - 1.59 per share. | Direct | 69,722 | Dec 28, 2023 |
PAULS MATTHEW Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 28, 2023 |
LOWRANCE DAVID L. CPA Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 15, 2023 |
HAWKINS RICHARD JAMES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
ELAM NEVAN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
LOWRANCE DAVID L. CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
PRATT RAYMOND DENNIS M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
PAULS MATTHEW Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
MCCRACKEN JOSEPH S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
LUTZ ROBERT MATTHEW Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
VAN ES-JOHANSSON AN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
SUN RICKY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 14, 2023 |
HAWKINS RICHARD JAMES Director | Conversion of Exercise of derivative security at price 0.82 per share. | Direct | 8,890 | Dec 11, 2023 |
ELAM NEVAN C Director | Conversion of Exercise of derivative security at price 0.82 per share. | Direct | 8,890 | Dec 11, 2023 |
BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
MATHERS EDWARD T. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
WALKER PAUL EDWARD Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
FLORENCE ANTHONY A JR Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
BEHBAHANI ALI Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
MAKHZOUMI MOHAMAD Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
CHANG CARMEN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
SANDELL SCOTT D Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
YANG RICK Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
GROWTH EQUITY OPPORTUNITIES 17, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.00 per share. | Indirect | 999,999 | Jul 17, 2023 |
PRATT RAYMOND DENNIS M.D. Officer | Purchase at price 2.93 per share. | Direct | 19,045 | Jun 26, 2023 |
LUTZ ROBERT MATTHEW Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
23.86
+3.16%
SLNO Soleno Therapeutics, Inc.
45.18
-0.04%
STOK Stoke Therapeutics, Inc.
11.68
+3.36%
VCNX Vaccinex, Inc.
1.4100
0.00%
VIGL Vigil Neuroscience, Inc.
1.7000
+2.41%
NUVB Nuvation Bio Inc.
2.6800
-0.37%
MRSN Mersana Therapeutics, Inc.
1.6000
-8.05%
RYTM Rhythm Pharmaceuticals, Inc.
56.12
+1.15%
ALXO ALX Oncology Holdings Inc.
1.6200
+9.46%
INZY Inozyme Pharma, Inc.
2.9900
+6.41%